Emergence and high prevalence of acute diseases including urinary tract infection, typhoid, tuberculosis, influenza, and sepsis along with the need for effective infection control procedures within healthcare units are the key drivers for the global market growth for infection surveillance solutions. Besides, stringent government regulations and policies to restrict and avoid infections in healthcare units further show a positive impact on the global infection surveillance solutions system market. Hence, various healthcare centers including clinics, hospitals, outpatient care settings are implementing infection surveillance solutions in terms of safety which will promote the growth of the market worldwide. Additionally, other drivers such as increasing attention toward reducing healthcare-acquired infections (HAI), the availability of latest surveillance technologies including data mining surveillance coupled with HAI surveillance workflow, and the rising number of various invasive procedures further contribute to the growth of the global infection surveillance solutions system market. However, issues related to software integration, lack of sanitation, less expenditure for the adoption of infection surveillance solutions along with lack of awareness related to hygiene in developing countries are likely to hinder the growth of the global infection surveillance solutions market over the forecast period.
Growing technological advancement in IT system along with the rising capacity of IT system to perform analytic processing drive the growth of the global market
IT systems help in emerging analytical and infection surveillance solutions for application in the healthcare industry along with automated HAI surveillance are further shows a positive impact on the market across the globe. Based on types of offered solutions, the global infection surveillance solutions market is classified into software and services. The software segment is likely to dominate the global market as compared to service owing to high demand and perpetual evolution og software in terms patient data, analysis and interpretation.
North America is likely to hold the highest revenue share in the global market
Geographically global infection surveillance solutions market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Among these regions, North America is likely to hold the largest market share owing to the large concentration of medical technology research industries. Other factors such as increasing R&D in medical science and a growing number of HAI patients are propelling the growth of the market in North America. According to an article published in the Centers for Disease Control and Prevention (CDC), in American hospitals alone, approx 1.7 million infections and 99,000 associated deaths are estimated each year; where 32% of all HAIs are urinary tract infections and 22% are surgical site infections. Therefore, as a result, demand for infection surveillance solutions is rising to avoid the infectious disease across the region, which further propelling the significant growth in the North American market.
Key Market Players
- Becton, Dickinson and Company
- Premier Inc.
- Wolters Kluwer N.V.
- Baxter International Inc.
- Gojo Industries, Inc.
- RadicaLogic Technologies, Inc.
- Truven Health Analytics Inc
- DEB Group Ltd.
- Hygreen, Inc.
Market Segments: Global Infection Surveillance Solutions Market
- By Offering
- Software
- On-Premise
- Cloud
- Service
- Maintenance and Support
- Consultation and Training
- Implementation Service
- Software
- By End-users
- Hospitals
- Long-term Care Facilities
- Others
- By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Asia Pacific
- China
- India
- Japan
- Middle East & Africa
- UAE
- South Africa
- Central & South America
- Brazil
- Mexico
- North America
Key Sources
- Industry Associations
- Research Papers
- Company Annual Reports
- Company Websites
- Key industry leaders
- Technology consultants
- Others
Key Questions Answered
- What are the key growth regions and countries?
- What are the important types and technologies being used?
- What are the market players doing, in terms of research and development?
- What is the recent news, developments, mergers, or large value deals?
- Where will the industry go in the long run?
Key Stakeholders
- Research & consulting firms, venture capitalists, private equity firms, and startup companies
- Infection surveillance solutions manufacturers, suppliers, and distributors
- Pharmaceutical and biotechnology companies
- Healthcare institutions
- Business research and consulting firms
- Government and regulatory authorities